1. Amirthalingam G, Andrews N, Keel P, et al. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet Public Health 2018;3:e82.

2. Yang Q, Chang A, Tong X, Merritt R. Herpes zoster vaccine live and risk of stroke among medicare beneficiaries: a population-based cohort study. Stroke 2021;52:1712–1721.

3. Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med 2014;371:1526–1533.

4. Walia A, Sun Y, Acharya NR. Risk of herpes zoster ophthalmicus recurrence after recombinant zoster vaccination. JAMA Ophthalmol 2024;142:249–256.

5. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009;8:731–740.

6. Mbinta JF, Nguyen BP, Awuni PMA, Paynter J, Simpson CR. Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis. Lancet Healthy Longev 2022;3:e263.

7. Zerbo O, Bartlett J, Fireman B, et al. Effectiveness of recombinant zoster vaccine against herpes zoster in a real-world setting. Ann Intern Med 2024;177:189–195.

8. Tricco AC, Zarin W, Cardoso R, et al. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. BMJ 2018;363:k4029.

9. Eyting M, Xie M, Michalik F, Heß S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature 2025;641:438–446.

10. Toffaha A, El Ansari W, Ramzee AF, Afana M, Aljohary H. Rare presentation of primary varicella zoster as fatal fulminant hepatitis in adult on low-dose,short-term steroid: case report. Ann Med Surg (Lond) 2019;48:115–117.

11. Brewer EC, Hunter L. Acute liver failure due to disseminated varicella zoster infection. Case Reports Hepatol 2018;2018:1269340.

12. Wang Z, Ye J, Han YH. Acute pancreatitis associated with herpes zoster: case report and literature review. World J Gastroenterol 2014;20:18053–18056.

13. Jeon D, Kim YJ, Kim S, et al. Liver cirrhosis increases the risk of herpes zoster: a nationwide population-based cohort study. Am J Gastroenterol 2023;118:1592–1600.

14. Oh J, Lee M, Kim M, et al. Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK. Nat Commun 2024;15:2830.

15. Oh J, Lee M, Park J, et al. Prenatal and postnatal exposure to antibiotics and risk of food allergy in the offspring: a nationwide birth cohort study in South Korea. Pediatr Allergy Immunol 2024;35:e14114.

16. Mbinta JF, Wang AX, Nguyen BP, et al. Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study. Lancet Reg Health West Pac 2022;31:100601.

17. Lee K, Park J, Lee J, et al. Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK. Clin Mol Hepatol 2024;30:943–958.

18. Park S, Kim HJ, Kim S, et al. National trends in physical activity among adults in South Korea before and during the COVID-19 pandemic, 2009-2021. JAMA Netw Open 2023;6:e2316930.

19. Klein NP, Bartlett J, Fireman B, et al. Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records. BMJ 2023;383:e076321.

20. Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis 2014;58:1497–1503.

21. Nakayama T, Sawada A, Ito T. Increased production of inflammatory cytokines after inoculation with recombinant zoster vaccine in mice. Vaccines (Basel) 2022;10:1339.

22. Sullivan NL, Eberhardt CS, Wieland A, Vora KA, Pulendran B, Ahmed R. Understanding the immunology of the Zostavax shingles vaccine. Curr Opin Immunol 2019;59:25–30.

23. Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system – prognosis, diagnostics and treatment. J Infect 2015;71:281–293.

24. Shore B, Fix OK, Hansen JJ. Disseminated varicella-zoster and acute liver failure in a patient with Crohn's disease on systemic immunosuppression. ACG Case Rep J 2025;12:e01611.

25. Williams R, Riordan SM. Acute liver failure: established and putative hepatitis viruses and therapeutic implications. J Gastroenterol Hepatol 2000;15 Suppl:G17–G25.

26. Br VK, Sarin SK. Acute-on-chronic liver failure: terminology, mechanisms and management. Clin Mol Hepatol 2023;29:670–689.

27. Jalan R, Moreau R, Arroyo V. Acute-on-chronic liver failure. Reply. N Engl J Med 2020;383:893–894. 28. Boutry C, Hastie A, Diez-Domingo J, et al.; Zoster-049 Study Group. The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase 3 clinical trials ZOE-50 and ZOE-70. Clin Infect Dis 2022;74:1459–1467.

29. Cunningham AL, Lal H, Kovac M, et al.; ZOE-70 Study Group. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 2016;375:1019–1032.

30. Høeg TB, Duriseti R, Prasad V. Potential "healthy vaccinee bias" in a study of BNT162b2 vaccine against Covid-19. N Engl J Med 2023;389:284–285.

31. Rubin E. Striving for diversity in research studies. N Engl J Med 2021;385:1429–1430.

32. Taquet M, Dercon Q, Todd JA, Harrison PJ. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med 2024;30:2777–2781.